Aandeel Pharming Group AEX:PHARM.NL, NL0010391025

quote:

antop schreef op 16 oktober 2019 13:55:

[...]
2019 Q1 WINST en Q2 WINST! en Q3 2019 WINST..logisch dat de concurrent actie onderneemt..personeel loopt weg naar de concurrent...en je product isduurder en verkoopt minder, want dat gaat o.a naar Pharming met Ruconest..en er komt meer aan in de pijplijn..ik zeg mooi instap moment als je ze nu niet hebt.

quote:

Tartessos schreef op 16 oktober 2019 13:47:

Deze hele exercitie gaat heel goed uitpakken voor Pharming.
Sijmen de Vries zou datgene waarvan pharming wordt beschuldigt NOOIT doen.
En Joe Chiao zou NOOIT zo dom zijn om het op deze wijze te doen.
Het zijn intelligente mensen!

Het CSL verhaal riekt naar de misdaad .
Overigens vreemd dat de rechter in USA uitspraak moet doen.
Groot - groter - grootst

quote:

tiekoes6 schreef op 16 oktober 2019 13:46:

Bizar blijft het of voelen ze dat Pharming een zuiver probuct op de markt hebben en de markt over gaat nemen.
Wat is de rede dit vlak voor de cijfers naar buiten te gooien.

quote:

Beur schreef op 16 oktober 2019 13:39:

[...]Niet echt.

Full Year 2019 CSL Ltd Earnings Call "Victoria Sep 3, 2019

"Demand for our specialty products remains robust with sales of HAEGARDA up 61%

finance.yahoo.com/news/edited-transcr...

quote:

De Monitor schreef op 16 oktober 2019 14:00:

[...]

Wat staat die oude rommel hier te doen? Kun je die lappen oude rommel op je eigen draad posten? Daar komt toch niemand.

quote:

twopence schreef op 16 oktober 2019 14:00:

[...]Zelf aandelen inslaan. Straks een melding dat de concurrent een positie heeft ingenomen. :-)

quote:

Pharminglover. schreef op 16 oktober 2019 14:01:

Moeten we nog met 2018....toen was er nog geen spionage....toch?

quote:

Beur schreef op 16 oktober 2019 13:41:

[...]Aandurven? Pharming zal wel moeten, die rechtzaak....

Verder was het inderdaad netter geweest wanneer Pharming haar aandeelhouders in een eerder stadium had geïnformeerd over de aanklacht.

quote:

Tartessos schreef op 16 oktober 2019 14:03:

Eens met Antop.
Het verhaal klopt gewoon niet. Medewerker die plotseling ontslag neemt (zonder een opzegtermijn).
Een kassa medewerker heeft zelfs een opzegtermijn.

quote:

Beur schreef op 16 oktober 2019 14:03:

Hieronder de integrale tekst van het artikel uit de Sydney Morning Herald. Boeiende stof. Dr.Chiao en Pharming hebben wel wat uit te leggen.

One million pages stolen': Aussie giant accuses former exec of espionage
October 16, 2019

Australian blood giant CSL has been rocked by an alleged corporate espionage attack, with a former "high level" employee accused of stealing tens of thousands of its documents - including trade secrets - in order to land a job at a key competitor.

CSL's main operating subsidiary, CSL Behring, has launched court action in America alleging its competitor, Dutch pharmaceuticals group Pharming, and former CSL senior medical officer Joe Chiao misappropriated CSL's trade secrets when they took 25 gigabytes of data.
Court documents reveal that CSL alleges the raid pilfered 1 million pages of company information across 21,000 files. CSL last week secured a temporary injunction against Dr Chiao and Pharming.

Born out of Commonwealth Serum Laboratories, CSL is Australia’s third largest publicly listed company and considered one of the country’s best ever exports with operations around the world and a market capitalisation of $114 billion. On Wednesday its shares, held by all major Australian super funds, hit a fresh record high of $253.83.

Following an inquiry from The Age and The Sydney Morning Herald this morning, CSL disclosed the court case at its annual general meeting on Wednesday.

CSL chief executive Paul Perreault told the company’s shareholder meeting: "It’s basically a case that’s in litigation or soon to go under litigation, and it was caught by our cybersecurity."

CSL has asked the US District Court of Pennsylvania for a permanent injunction against Dr Chiao and Pharming using its information and compensatory and punitive damages against the doctor and its competitor.

CSL’s allegations are expected to reverberate through the highly competitive global drug making industry where trade secrets are the most prized possession of the companies.

Dr Chiao, a specialist in a rare blood disease, resigned on September 23, sparking an internal investigation into his sudden departure which uncovered emails, texts and a clandestine meeting at a hotel in Budapest, according to the court documents.

The internal investigation found that over the months before his resignation Dr Chiao had allegedly engaged in talks with senior executives at Pharming and offered to take information from CSL.

He later secured a senior position at the Dutch group. The secrets allegedly targeted were initially related to only one of CSL’s products, a treatment for the rare disease hereditary angioedema, which was Dr Chiao's area of expertise.

However, Dr Chiao is also accused in the documents of taking secrets relating to a vast number of CSL’s products, including its research and development of treatments for common blood disorders – the backbone of CSL’s business.

According to the court documents filed by CSL, Dr Chiao in May this year met with Pharming vice president of clinical research and medical affairs Anurag Relan at a hotel in Budapest close to where a major medical conference was taking place, "presumably to avoid being seen together".

After that meeting Dr Chiao and Mr Relan continued to communicate via text messages, the court documents allege.

These messages include Dr Chiao telling Mr Relan: "I’m hopeful that you will be able to convince your boss regarding how we would align together to effect a large difference to the bottom line of Pharming."

Mr Relan replied: "Joe, I had a chat with our COO and he is supportive ... Thanks and excited about the possibilities."

Another message allegedly shows Dr Chiao telling Mr Relan about a new product CSL was developing: "I can bring this concept to Pharming. Nothing has been signed yet…"

Other messages allegedly show Dr Chiao shared portions of the secret manuscript prepared by an association CSL is a member of about key drug developments.
"I’m not even sharing the manuscript internally at CSL," Dr Chiao said in a text message cited in the documents.
CSL alleges Dr Chiao then shared portions of the manuscript with Mr Relan. It also alleges Mr Relan encouraged Dr Chiao to send through information that would help Pharming. In September this year, Pharming offered Dr Chiao a plum job.

"Having spent months exchanging ideas and information with Pharming, Chiao was finally offered employment as Pharming’s executive medical director in mid-September 2019," CSL alleges in its complaint.

CSL alleges Dr Chiao resigned on September 23 giving two weeks’ notice, but was supposed to start at Pharming on September 30, "meaning he presumably intended to work for both CSL Behring and Pharming for one week."

"This is particularly troubling given that before he notified anyone at CSL Behring that he was leaving, Chiao spent the weekend emailing and downloading documents from CSL Behring’s computer systems," CSL said in its court filings.

Pharming has been contacted for comment and Dr Chiao has not responded to the allegations. CSL provided a statement today that was later read in part by its CEO at its AGM.

quote:

Tartessos schreef op 16 oktober 2019 14:03:

Eens met Antop.
Het verhaal klopt gewoon niet. Medewerker die plotseling ontslag neemt (zonder een opzegtermijn).
Een kassa medewerker heeft zelfs een opzegtermijn.